The American Brain Tumor Association is accepting Letter of Intent Applications for Research Collaboration Grants, Discovery Grants, and Basic Research Fellowships through November 14, 2018. All recipients of these grants become members of the ABTA Alumni Research Network and are invited to the annual meeting in Chicago.
Justin Lathia, PhD, an associate professor and researcher in the Department of Cellular and Molecular Medicine at the Lerner Research Institute of the Cleveland Clinic, discusses the importance of ABTA grants.
CONTINUE READING & SUBMIT AN APPLICATION
Colleen Kelley ran the 2018 Chicago Marathon for the American Brain Tumor Association in honor of her friend, Grace. Watch her two-part inspiring story.
An Interview with Steve Welhoelter
What type of brain tumor were you diagnosed with, and when?
I was diagnosed with a glioblastoma in March, 2014. I followed the standard of care and have been on Optune since January, 2015. I have remained progression free since.
How has your life changed as a result of a brain tumor diagnosis?
I have been incredibly lucky. The only deficit I have from my episode with GBM is a minor problem with the control of my left leg…
CONTINUE READING STEVE’S STORY
NOV 3, 2018 |
NOV 11, 2018 |
NOV 15, 2018 |
About Meet Hope Head On
Because of the generous support from people like you, the ABTA has given over $35 million for brain tumor research. The ABTA’s campaign, “Meet Hope Head On,” created for our 50th anniversary, is focused on raising $50 million, in part to fund critical brain tumor research. This campaign is vital for continuing the kind of work that led to the recent FDA approval of vorasidenib, a breakthrough treatment for low-grade glioma.
